The Septavalent vaccine is generally referred to as the nine-valent HPV vaccine, which focuses on preventing cancers such as cervical precancerous lesions, cervical cancer, vaginal epithelial cancer, and anal cancer.
Nine-valent HPV vaccine mainly prevents nine high-risk types of HPV viruses, i.e. human papillomavirus infections. After vaccination, patients can not only prevent cervical cancer, but also cervical precancerous lesions, vaginal epithelial cancer, anal cancer and other cancers caused by HPV infection. In addition, it can also prevent lesions such as condyloma acuminatum.
The age for the nine-valent HPV vaccine is between 16 and 26 years old, and it is important to follow the doctor’s instructions strictly when receiving the vaccine. If you are a married woman or a female patient with a sexual life before receiving the nine-valent HPV vaccine, you need to do cervical HPV and TCT examination.
Patients need to observe more body symptoms after vaccination, if there are obvious dizziness, headache, fever and other uncomfortable symptoms, they should consult a doctor in time for standardized treatment.